Pharma Marketing Network

JULY 21, 2023

The pharmaceutical industry is a highly regulated one, and as such, traditional marketing channels such as advertising can be limited. However, content marketing is a great way for pharmaceutical companies to reach their target audience and drive sales.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

APRIL 11, 2022

Pharmaceutical companies have said they will try to carve months off the time between approval and launch for new medicines in Europe, and reduce disparities between access between countries. — EFPIA (@EFPIA) April 11, 2022.

Documentation 52

Documentation Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

JUNE 6, 2025

In one of the fierier remarks from the roundtable, RFK Jr said: “At every level, doctors, other providers, our hospitals, the pharmaceutical companies, the insurance companies, all make money by keeping us sick. We need to fundamentally change that so that we are focusing on curing disease and making people better.”

Communication 52

Communication Hospitals Insurance FDA 52

ISPE

MAY 1, 2023

To reduce the risk of cleanroom contamination, and in collaboration with a leading pharmaceutical company, UV Medico has designed a breakthrough technology: The UV222 Booth. Download White Paper To download this white paper, complete the form below.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

NOVEMBER 3, 2021

Committed to innovation, product excellence, and customer success, Veeva serves more than 1,100 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is the global leader in cloud software for the life sciences industry.

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies Communication 98

pharmaphorum

MAY 13, 2021

Committed to innovation, product excellence, and customer success, Veeva serves more than 975 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is the global leader in cloud software for the life sciences industry.

Communication 105

Communication Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

NOVEMBER 14, 2022

In order to incentivise innovative medicines, health technology assessment (HTA) bodies should consider evaluating the benefits that greener medicines bring to society and drive this change in the companies that are better capitalised to do so.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

FEBRUARY 17, 2023

However, Amgen and other pharmaceutical companies have been criticised when they opted to choose the drug’s dosage based on the MTD model, which is commonly used in dose-finding trials. Impact on the industry Veal says that for a lot of pharmaceutical companies there is no “big drive to think about optimizing treatment” post-licensing.

Dosage 115

Dosage FDA Pharmaceutical Companies Pharmaceutical Companies 115

Pharmaceutical Technology

DECEMBER 19, 2022

This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. While larger, more established pharmaceutical companies may have the infrastructure and financial cushion to fall back on, SMEs need to tread carefully through these economic challenges.

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Generic Medicine Communication 69

pharmaphorum

OCTOBER 27, 2020

Given the recent rise in digital engagement and the drastic increase in digital content, it’s now essential that pharmaceutical companies have a comprehensive content strategy. This enables pharma companies to simplify management of digital assets and speed up the creation, and review of new promotional materials.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies 64

pharmaphorum

JUNE 1, 2022

To help pharmaceutical companies reach patients broadly and get them engaged in meaningful actions to improve their health outcomes, this whitepaper analyses: How behavioural science can achieve lasting change.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Pharmaceutical Companies 64

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 64

Pharmaceutical Technology

MARCH 17, 2023

GlobalData calculates these risk scores by evaluating several qualitative and quantitative factors to establish the quality of conditions and the level of stability of the market access environment encountered by pharmaceutical companies in each country.

Pharmaceutical Companies 102

Pharmaceutical Companies Pharmaceutical Companies Communication 102

Pharmaceutical Technology

JANUARY 16, 2023

This could evolve into pharmaceutical companies dealing with semi-permanent higher input costs and other interlinked challenges for longer than current baseline predictions. The magnitude of the hindrance to sales growth and profitability will impact companies from multiple different angles.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Hospitals 52

European Pharmaceutical Review

DECEMBER 21, 2022

“As the contribution of costs of organic chemicals used as feedstock to the operating expenditures is small, the pharmaceutical companies can spearhead and guide the transition.” Design of a Continuous Solvent Recovery System for End-to-End Integrated Continuous Manufacturing of Pharmaceuticals. 199‒208.

Compounding 97

Compounding Pharmaceutical Companies Pharmaceutical Companies Packaging 97

Pharmaceutical Technology

FEBRUARY 3, 2023

These single-use technologies allow pharmaceutical companies to achieve continuous manufacturing, which significantly reduces the risk of cross-contamination without the need for extensive cleaning and disinfecting.

Packaging 52

Packaging Dosage Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 28, 2023

For many years, the pharmaceutical industry has been accused of overlooking this patient population by instead targeting investments toward more prevalent indications. The stakes are high when launching an orphan drug product, however.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

FEBRUARY 28, 2023

Celnova Pharma is an Argentina-based pharmaceutical company that centres its work around rare diseases, oncology, central nervous system, diabetes and critical care. The company currently has operations in Argentina, Colombia, Chile, Peru, and Uruguay.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

FEBRUARY 6, 2023

According to Baker Mackenzie , a law firm brand that specialises in a range of industries including healthcare and life sciences, IPOs allow pharmaceutical companies to “access major global finance hubs and capital from a deep pool of investors around the world”.

FDA 59

FDA Pharmaceutical Companies Pharmaceutical Companies Communication 59

Pharmaceutical Technology

DECEMBER 15, 2022

One antimicrobial agent that pharmaceutical companies have turned to time and time again is Benzalkonium Chloride (BKC) – a well-known quaternary ammonium compound that has supported pharmaceutical formulations as far back as the 1940s. Is Benzalkonium Chloride a good choice?

Documentation 52

Documentation Compounding Communication Pharmaceutical Companies 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies 86

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 86

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 52

Pharmaceutical Technology

DECEMBER 6, 2022

Explaining the rise of HPAPIs, Bruno Villa, CEO, MEDELPHARM believes the trend is a consequence of the increasing pressure on pharmaceutical companies to develop drugs with improved efficiency and efficacy. Within that figure, GlobalData estimates that around 60% of pipeline HPAPIs are developed to target oncology.

Dosage 52

Dosage Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

DECEMBER 22, 2022

As pharmaceutical companies launch their products across European countries, the joint procedure is intended to reduce the duplication of submissions with different evidence requirements and procedural times required at a country level, and thus streamline workflows and reduce administrative burden.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Labelling Communication 52

Pharmaceutical Technology

FEBRUARY 9, 2023

This guidance has driven many pharmaceutical companies to revaluate their approach to CCIT. According to Lukas Engel, market manager pharma CCIT at Pfeiffer Vacuum, companies are increasingly looking to perform high throughput testing with sophisticated, deterministic methods.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Communication 52

Pharmaceutical Technology

FEBRUARY 7, 2023

Starting research early and using the findings to inform R&D decisions gives pharmaceutical companies the best chance of success when they come to scale the many market access obstacles presented by Europe. Overall, it is never too soon to begin market access activities, but it can easily be too late.

Packaging 52

Packaging Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies 89

Pharmaceutical Companies Pharmaceutical Companies FDA 89

Pharmaceutical Technology

MARCH 6, 2023

The CLR is a great option for pharmaceutical companies performing steam sterilisation in the drying chamber. The CLR is temperature controlled to 160°C, enabling the highest accuracy and protection against condensation. But that isn’t the only demanding application in the freeze drying world.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication 52

pharmaphorum

JANUARY 14, 2021

Not so China, and especially not so the lead five European countries – on average European pharmaceutical companies saw a loss of 30% of the interactive time they previously had with healthcare professionals in 2020. Up to November, the US and Japan actually saw increases in interactive time in 2020. Pharma pivots East.

Pharmaceutical Companies 70

Pharmaceutical Companies Pharmaceutical Companies Labelling 70

ISPE

JANUARY 3, 2023

A landmark project for a major international pharmaceutical company was the starting point for a series of follow-up projects in Switzerland and Germany. . Download White Paper. To download this white paper, complete the form below. Company Name. Company Type. Company Type.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Communication Vaccines 52

Pharmaceutical Technology

MARCH 22, 2023

In the 1990s, generic pharmaceutical companies in the European Union (EU) offshored the manufacturing of active pharmaceutical ingredients (API) primarily to China. It was a money-saving strategy that was paying off until Covid-19 hit.

Packaging 105

Packaging FDA Pharmaceutical Companies Pharmaceutical Companies 105

Pharmaceutical Technology

MARCH 6, 2023

He goes on to say that this might incentivize more pharmaceutical companies to develop drugs that target the biology of aging. The incentive from the FDA’s perspective would be the possible larger effect size on multiple age-related diseases compared to that of drugs currently being developed,” he says.

FDA 145

FDA Labelling Pharmaceutical Companies Pharmaceutical Companies 145

Pharmaceutical Technology

FEBRUARY 1, 2023

RSV researchers at major pharmaceutical companies are currently working to develop new RSV drugs to beat future waves of RSV infection and gain the first RSV vaccine FDA approval. Pharmaceutical companies are pushing to develop drugs and vaccines for RSV with these populations in mind.

Vaccines 64

Vaccines Pharmaceutical Companies Pharmaceutical Companies FDA 64

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 57

Pharmaceutical Companies Pharmaceutical Companies FDA Vaccines 57

pharmaphorum

JUNE 29, 2022

She has an extremely wide experience of international pharmaceutical industry issues, consulting to the world’s leading pharmaceutical companies on global issues. She has been vice resident, European Marketing and Thought Leadership in IQVIA for 12 years. the impact of the pandemic on medicines markets and Rx launch.

HIV Treatment and Prevention Agents 59

HIV Treatment and Prevention Agents Pharmaceutical Companies Pharmaceutical Companies Vaccines 59

ISPE

NOVEMBER 1, 2022

QMM encompasses a range of actions including metrics, leadership commitment, culture, sustainable compliance, enhanced pharmaceutical quality systems, continual improvement, and risk management. QMM rating program is necessary to ensure patients have consistent access to the drugs they need. Next Slide ??. Michael Kopcha. Thomas Wozniewski.

FDA 98

FDA Insurance Chemotherapy Documentation 98

ISPE

JULY 5, 2023

For example, one pharmaceutical company that switched to CM reported a 50% reduction in operating costs, a 33% reduction in waste, an 80% reduction in manufacturing and testing cycle time, and a 66% reduction in time from testing to release. Journal of Pharmaceutical Sciences 104, no. White Paper on Continuous Bioprocessing.”

FDA 52

FDA Dosage Documentation Pharmaceutical Companies 52